Andrea Botticelli

Pubblicazioni

Titolo Pubblicato in Anno
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis CANCERS 2024
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey TUMORI 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients CURRENT ONCOLOGY REPORTS 2024
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line JOURNAL OF TRANSLATIONAL MEDICINE 2024
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study THE ONCOLOGIST 2024
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis BMC CANCER 2024
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024
Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge DIAGNOSTICS 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach CANCER IMMUNOLOGY, IMMUNOTHERAPY 2023
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma JOURNAL OF THORACIC ONCOLOGY 2023
Risk of Oral Squamous Cell Carcinoma in One Hundred Patients with Oral Lichen Planus: A Follow-Up Study of Umberto I University Hospital of Rome CANCERS 2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma LUNG CANCER 2023
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer CLINICAL CANCER RESEARCH 2023
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors FRONTIERS IN IMMUNOLOGY 2023
Network approach in liquidomics landscape JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2023
The impact of drug–drug Interactions on the toxicity profile of combined treatment with BRAF and MEK Inhibitors in patients with BRAF-mutated metastatic melanoma CANCERS 2023
Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 2023
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey TUMORI 2023

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma